Synklino

0 followers


Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection.

Industries

Headquarters

Stage

Employees

Links

Org chart

Thomas Kledal
CEO & Co-Founder

Thomas Kledal

Collapse
Mads Jeppesen
CMC Project Director & Co-Founder
Josi Holz
Senior Strategic Advisor
Mads Gravers Jeppesen
Head of Discovery
Mette M Rosenkilde
Member of the Board of Directors & Co-Founder
Romain LALANDES
Head of BD
Søren Neve
Head of Pharmacology
Mette Bøgh Winckler
Executive Assistant